The unveiling of a novel mechanism of resistance to immunotherapy targeting HER2
Immunotherapy continues to show exciting promise in more effectively combating several tumour types. Many current…
Browsing: HER2
Major trial uses blood test to match women with breast cancer to range of precision treatments
A blood test that can identify a variety of mutations in advanced breast cancer can…
A one-step diagnostic may bring faster, cheaper cancer testing to remote settings
Scientists have created a rapid and affordable test for breast cancer that is designed for…
Researchers uncover hereditary mutation that drives aggressive head and neck, and lung cancers in Asian population
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of…
De-escalating breast cancer therapy; can some patients be spared chemotherapy?
About one of every five breast cancers presents with high levels of HER2 proteins. Known…
HER2 positive breast cancer: Treatment de-escalation needs to be personalised
De-escalation approaches in the treatment of women with HER2 positive breast cancer need to be…
Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug
An antibody that binds simultaneously to two distinct regions of the HER2 receptor to block…
Will tarloxotinib finally break the HER2 barrier in lung cancer?
The HER2 gene is a well-known driver of breast cancer, where changes in this gene…
ESMO 2018: Shorter-course trastuzumab could be an option in HER2 positive early breast cancers
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower…
Potential new approach to treat HER2 positive breast cancer
Researchers at Mayo Clinic have identified an important new pathway by which HER2 positive breast…